Medpace/MEDP
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX
About Medpace
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Ticker
MEDP
Sector
Healthcare
Trading on
NASDAQ
Industry
Life Sciences Tools and Services
Headquarters
Cincinnati, United States
Employees
5,800
Website
www.medpace.com
Medpace Metrics
BasicAdvanced
$13B
Market cap
41.20
P/E ratio
$9.82
EPS
1.40
Beta
-
Dividend rate
Price and volume
Market cap
$13B
Beta
1.4
Financial strength
Current ratio
0.779
Quick ratio
0.717
Long term debt to equity
20.275
Total debt to equity
20.275
Management effectiveness
Return on assets (TTM)
13.89%
Return on equity (TTM)
61.35%
Valuation
Price to earnings (TTM)
41.2
Price to revenue (TTM)
6.32
Price to book
18.56
Price to tangible book (TTM)
-473.99
Price to free cash flow (TTM)
26.21
Growth
Revenue change (TTM)
25.57%
Earnings per share change (TTM)
24.74%
3-year revenue growth
27.14%
3-year earnings per share growth
32.47%
What the Analysts think about Medpace
Analyst Ratings
Majority rating from 8 analysts.
Medpace Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$511M
2.53%
Net income
$103M
31.07%
Profit margin
20.05%
27.79%
Medpace Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$1.93
$2.22
$2.46
$3.20
-
Expected
$1.91
$2.05
$2.22
$2.47
$2.53
Surprise
0.79%
8.50%
10.71%
29.82%
-
Medpace News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Medpace stock?
Medpace (MEDP) has a market cap of $13B as of July 03, 2024.
What is the P/E ratio for Medpace stock?
The price to earnings (P/E) ratio for Medpace (MEDP) stock is 41.2 as of July 03, 2024.
Does Medpace stock pay dividends?
No, Medpace (MEDP) stock does not pay dividends to its shareholders as of July 03, 2024.
When is the next Medpace dividend payment date?
Medpace (MEDP) stock does not pay dividends to its shareholders.
What is the beta indicator for Medpace?
Medpace (MEDP) has a beta rating of 1.4. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Medpace stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.